Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection
Clinical trial NCT04690387 · COMPLETED
Trial details
- NCT number
- NCT04690387
- Sponsor
- Aivita Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-01-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.